Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$127.59 - $203.08 $255 - $406
2 Added 33.33%
8 $1,000
Q4 2022

Feb 01, 2023

SELL
$117.37 - $139.17 $352 - $417
-3 Reduced 33.33%
6 $0
Q3 2022

Nov 03, 2022

SELL
$135.27 - $180.11 $405 - $540
-3 Reduced 25.0%
9 $1,000
Q2 2022

Aug 09, 2022

BUY
$108.81 - $179.33 $326 - $537
3 Added 33.33%
12 $2,000
Q1 2022

Apr 22, 2022

BUY
$119.61 - $157.85 $1,076 - $1,420
9 New
9 $1,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Disciplined Investments, LLC Portfolio

Follow Disciplined Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Investments, LLC with notifications on news.